Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of a Tissue Immune Profile (TIP) in Patients Affected by Metastatic TNBC Treated With Upfront Atezolizumab Plus Nab-paclitaxel (TIP)

NCT05831553 is registered in ClinicalTrials.gov with Fondazione per la Medicina Personalizzata as lead sponsor.

NCT NCT05831553
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05831553 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of a Tissue Immune Profile (TIP) in Patients Affected by Metastatic TNBC Treated With Upfront Atezolizumab Plus Nab-paclitaxel (TIP)
Lead sponsor
Fondazione per la Medicina Personalizzata
Phase
Observational
Overall status
Unknown status
Start date
September 16, 2022
Completion date
September 16, 2025
Enrollment
100 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic triple-negative breast cancer